OSF Little Company of Mary Medical Center

Patient Safety - All

Healthcare-Associated Infections

Hospitals in Illinois are participating in programs to reduce the number of infections acquired during hospital stays. While it is difficult to reduce infections to zero, following specific protocols can greatly reduce the risk.

The Hospital Report Card Act (Illinois Public Act 93-563) requires Illinois hospitals to report central line associated bloodstream infections (CLABSIs) as well as surgical site infections (SSIs). As of January 1, 2012, hospitals are also mandated to report Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections and Clostridioides difficileinfections. Infections are reported through the CDC’s National Healthcare Safety Network (NHSN) surveillance system. The Standardized Infection Ratio (SIR), a summary measure used to determine whether infection data are statistically different from the national average, is presented for each type of infection shown below. Read more about healthcare-associated infections in Illinois. To learn more about the data collection methods using the CDC's National Health Safety Network (NHSN) surveillance system, read the Report Card methodology.

Clostridioides difficile infections (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections

Facility-wide Healthcare Facility Onset Incidence Rates for CDI and MRSA are presented below. These rates are based on results of laboratory tests that were obtained on or after day four of an inpatient stay and do not consider presence or timing of clinical signs or symptoms. The Standardized Infection Ratio (SIR) is presented, which is a summary measure used to determine if rates of CDI and MRSA bloodstream infections are statistically different from the national average. Statewide summaries of CDI and MRSA data arranged by hospital are also included. Note: Starting with 2016 data, new methods for risk adjustment were used.

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Footnotes

Key	Description
33	Complete Reporting: 50 or Less Central Line Days
38	Exempt: No Licensed PICU Beds
39	Exempt: No Licensed NICU Beds
42	Complete Reporting: Zero infections, but too few central line days to calculate a precise SIR
48	No Target Procedures Performed
114	Complete Reporting: Number of predicted events too low to calculate a precise SIR
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
153	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
169	Exempt: No Licensed ICU Beds

Central Line Associated Bloodstream Infections (CLABSIs)

Presented below are annual central line-associated bloodstream infections (CLABSIs) occurring in critical care units, also known as intensive care units (ICUs). ICU-specific summary data for CLABSI are provided using the Standardized Infection Ratio(SIR). Statewide summaries of CLABSI data arranged by ICU type and hospital are also included.

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Footnotes

Key	Description
33	Complete Reporting: 50 or Less Central Line Days
38	Exempt: No Licensed PICU Beds
39	Exempt: No Licensed NICU Beds
42	Complete Reporting: Zero infections, but too few central line days to calculate a precise SIR
48	No Target Procedures Performed
114	Complete Reporting: Number of predicted events too low to calculate a precise SIR
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
153	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
169	Exempt: No Licensed ICU Beds

Adult CLABSI

Pediatric CLABSI

Ped. CLABSI Measure	Result	SIR
Pediatric Medical-Surgical ICU Q1 2019 - Q4 2019 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Description Central Line-associated Bloodstream Infection (CLABSI) data in the Medical-Surgical Pediatric ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2018 - Q4 2018 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2017 - Q4 2017 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2016 - Q4 2016 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2015 - Q4 2015 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2014 - Q4 2014 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2013 - Q4 2013 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2012 - Q4 2012 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2011 - Q4 2011 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2010 - Q4 2010 Result 0 infections, 10 central-line days ³³ Rating SIR: 0.00 ³³	0 infections, 10 central-line days ³³	0.00 ³³
Q1 2010 - Q2 2010 Result 0 infections, 10 central-line days ³³ Rating SIR: N/A ³³	0 infections, 10 central-line days ³³	N/A ³³

NICU CLABSI

Surgical Site Infections (SSIs)

Presented below are data for surgical site infections associated with coronary artery bypass graft surgery (CABG) and total knee replacement surgery (KPROs) using the Standardized Infection Ratio (SIR). Superficial and secondary surgical site infections are not included in the summary data below. Statewide summaries of surgical site infection data arranged by surgical procedure (CABG, KPRO) and hospital are also included.

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Footnotes

Key	Description
33	Complete Reporting: 50 or Less Central Line Days
38	Exempt: No Licensed PICU Beds
39	Exempt: No Licensed NICU Beds
42	Complete Reporting: Zero infections, but too few central line days to calculate a precise SIR
48	No Target Procedures Performed
114	Complete Reporting: Number of predicted events too low to calculate a precise SIR
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
153	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
169	Exempt: No Licensed ICU Beds

Immunization Practices

Illinois hospitals are focusing their efforts on boosting immunization treatments and strengthening patient safety protocols. The objective is not merely achieving statistical success, but also enhancing the quality of care and patient well-being.

Data on immunization measures in Illinois hospitals is available through the Medicare comparison tool at medicare.gov/hospitalcompare. This tool provides valuable insights, allowing patients and their families to gauge the quality of care and safety practices at local hospitals, helping them make informed healthcare decisions.

In the realm of Patient Safety, a host of measures are assessed, with risk-adjusted rates available for each. These measures encompass various aspects of patient care and treatment outcomes. However, interpreting these metrics requires an understanding of the complexity and context-specific nature of healthcare.

Immunization

These indicators are used to measure immunization treatments at hospitals. This data comes from medicare.gov/hospitalcompare.

Measure	Result
Healthcare workers given influenza vaccination Q4 2022 - Q1 2023 Result 68.00 %	68.00 %
Description Influenza Vaccination Coverage among Healthcare Personnel Historical Data
Measure	Result
Q4 2021 - Q1 2022 Result 60.00 %	60.00 %
Q4 2020 - Q1 2021 Result 70.00 %	70.00 %
Q4 2019 - Q1 2020 Result 80.00 %	80.00 %
Q4 2018 - Q1 2019 Result 89.00 %	89.00 %
Q4 2017 - Q1 2018 Result 89.00 %	89.00 %

Illinois Hospital Report Card

and Consumer Guide to Health Care

OSF Little Company of Mary Medical Center

Patient Safety - All

Healthcare-Associated Infections

Clostridioides difficile infections (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections

Statistical Significance

Footnotes

Description

Historical Data

Description

Historical Data

Central Line Associated Bloodstream Infections (CLABSIs)

Statistical Significance

Footnotes

Adult CLABSI

Description

Historical Data

Pediatric CLABSI

Description

Historical Data

NICU CLABSI

Description

Historical Data

Description

Surgical Site Infections (SSIs)

Statistical Significance

Footnotes

Description

Historical Data

Description

Historical Data

Immunization Practices

Immunization

Description

Historical Data

Healthcare Facility Onset Incidence Rate	Result	SIR
Methicillin-resistant Staphylococcus aureus (MRSA) blood stream infections Q1 2023 - Q4 2023 Result 2 infections, 58163 patient days Rating SIR: 0.67	2 infections, 58163 patient days	0.67
Description Methicillin-resistant Staphylococcus aureus infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 2 infections, 62837 patient days Rating SIR: 0.63	2 infections, 62837 patient days	0.63
Q1 2021 - Q4 2021 Result 3 infections, 68275 patient days Rating SIR: 0.70	3 infections, 68275 patient days	0.70
Q1 2019 - Q4 2019 Result 0 infections, 61880 patient days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 61880 patient days ¹¹⁷	0.00 ¹¹⁷
Q1 2018 - Q4 2018 Result 1 infections, 59597 patient days Rating SIR: 0.31	1 infections, 59597 patient days	0.31
Q1 2017 - Q4 2017 Result 0 infections, 58695 patient days Rating SIR: 0.00	0 infections, 58695 patient days	0.00
Q1 2016 - Q4 2016 Result 1 infections, 58523 patient days Rating SIR: 0.31	1 infections, 58523 patient days	0.31
Q1 2015 - Q4 2015 Result 2 infections, 59352 patient days Rating SIR: 0.87	2 infections, 59352 patient days	0.87
Q1 2014 - Q4 2014 Result 4 infections, 65092 patient days Rating SIR: 1.15	4 infections, 65092 patient days	1.15
Q1 2013 - Q4 2013 Result 4 infections, 61694 patient days Rating SIR: 1.31	4 infections, 61694 patient days	1.31
Q1 2012 - Q4 2012 Result 1 infections, 61129 patient days Rating SIR: 0.30	1 infections, 61129 patient days	0.30
Q1 2012 - Q2 2012 Result 1 infections, 30651 patient days Rating SIR: 0.33	1 infections, 30651 patient days	0.33
Clostridioides difficile infections (CDI) Q1 2023 - Q4 2023 Result 7 infections, 55580 patient days Rating SIR: 0.25	7 infections, 55580 patient days	0.25
Description Clostridium difficile infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 6 infections, 60085 patient days Rating SIR: 0.13	6 infections, 60085 patient days	0.13
Q1 2021 - Q4 2021 Result 4 infections, 65442 patient days Rating SIR: 0.08	4 infections, 65442 patient days	0.08
Q1 2019 - Q4 2019 Result 17 infections, 59101 patient days Rating SIR: 0.35	17 infections, 59101 patient days	0.35
Q1 2018 - Q4 2018 Result 33 infections, 57144 patient days Rating SIR: 0.77	33 infections, 57144 patient days	0.77
Q1 2017 - Q4 2017 Result 40 infections, 56203 patient days Rating SIR: 0.91	40 infections, 56203 patient days	0.91
Q1 2016 - Q4 2016 Result 54 infections, 55697 patient days Rating SIR: 1.19	54 infections, 55697 patient days	1.19
Q1 2015 - Q4 2015 Result 56 infections, 56168 patient days Rating SIR: 1.14	56 infections, 56168 patient days	1.14
Q1 2014 - Q4 2014 Result 71 infections, 61549 patient days Rating SIR: 1.28	71 infections, 61549 patient days	1.28
Q1 2013 - Q4 2013 Result 97 infections, 57675 patient days Rating SIR: 1.74	97 infections, 57675 patient days	1.74
Q1 2012 - Q4 2012 Result 78 infections, 57973 patient days Rating SIR: 1.46	78 infections, 57973 patient days	1.46

Adult CLABSI Measure	Result	SIR
Adult Medical/Surgical ICU Q1 2023 - Q4 2023 Result 1 infections, 1552 central-line days Rating SIR: 0.66	1 infections, 1552 central-line days	0.66
Description Central Line-associated Bloodstream Infection data in the Adult Medical/Surgical ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 2 infections, 1718 central-line days Rating SIR: 1.19	2 infections, 1718 central-line days	1.19
Q1 2021 - Q4 2021 Result 3 infections, 2466 central-line days Rating SIR: 1.08	3 infections, 2466 central-line days	1.08
Q1 2019 - Q4 2019 Result 2 infections, 2024 central-line days Rating SIR: 1.14	2 infections, 2024 central-line days	1.14
Q1 2018 - Q4 2018 Result 1 infections, 1831 central-line days Rating SIR: 0.54	1 infections, 1831 central-line days	0.54
Q1 2017 - Q4 2017 Result 4 infections, 1974 central-line days Rating SIR: 2.01	4 infections, 1974 central-line days	2.01
Q1 2016 - Q4 2016 Result 4 infections, 2295 central-line days Rating SIR: 1.73	4 infections, 2295 central-line days	1.73
Q1 2015 - Q4 2015 Result 9 infections, 2404 central-line days Rating SIR: 2.50	9 infections, 2404 central-line days	2.50
Q1 2014 - Q4 2014 Result 4 infections, 2708 central-line days Rating SIR: 0.99	4 infections, 2708 central-line days	0.99
Q1 2013 - Q4 2013 Result 4 infections, 2136 central-line days Rating SIR: 1.25	4 infections, 2136 central-line days	1.25
Q1 2012 - Q4 2012 Result 6 infections, 2145 central-line days Rating SIR: 1.87	6 infections, 2145 central-line days	1.87
Q1 2011 - Q4 2011 Result 6 infections, 2648 central-line days Rating SIR: 1.51	6 infections, 2648 central-line days	1.51
Q1 2010 - Q4 2010 Result 1 infections, 3214 central-line days Rating SIR: 0.21	1 infections, 3214 central-line days	0.21
Q1 2009 - Q4 2009 Result 8 infections, 3062 central-line days Rating SIR: 1.74	8 infections, 3062 central-line days	1.74

NICU CLABSI Measure	Result	SIR
Level II/III Neonatal ICU Q1 2023 - Q4 2023 Result 0 infections, 42 central-line days Rating SIR: N/A	0 infections, 42 central-line days	N/A
Description Central Line-associated Bloodstream Infection data in the Level II/III Neonatal ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 0 infections, 63 central-line days ⁴² Rating SIR: N/A ⁴²	0 infections, 63 central-line days ⁴²	N/A ⁴²
Q1 2021 - Q4 2021 Result 1 infections, 29 central-line days ³³ Rating SIR: N/A ³³	1 infections, 29 central-line days ³³	N/A ³³
Q1 2019 - Q4 2019 Result 0 infections, 18 central-line days ³³ Rating SIR: N/A ³³	0 infections, 18 central-line days ³³	N/A ³³
Q1 2018 - Q4 2018 Result 0 infections, 4 central-line days ³³ Rating SIR: N/A ³³	0 infections, 4 central-line days ³³	N/A ³³
Q1 2017 - Q4 2017 Result 0 infections, 25 central-line days ³³ Rating SIR: N/A ³³	0 infections, 25 central-line days ³³	N/A ³³
Q1 2016 - Q4 2016 Result 0 infections, 15 central-line days ³³ Rating SIR: N/A ³³	0 infections, 15 central-line days ³³	N/A ³³
Q1 2015 - Q4 2015 Result 0 infections, 4 central-line days ³³ Rating SIR: N/A ³³	0 infections, 4 central-line days ³³	N/A ³³
Q1 2014 - Q4 2014 Result 0 infections, 0 central-line days ³³ Rating SIR: N/A ³³	0 infections, 0 central-line days ³³	N/A ³³
Q1 2012 - Q4 2012 Result 0 infections, 47 central-line days ³³ Rating SIR: N/A ³³	0 infections, 47 central-line days ³³	N/A ³³
Q1 2011 - Q4 2011 Result 0 infections, 146 central-line days Rating SIR: N/A	0 infections, 146 central-line days	N/A
Q1 2010 - Q4 2010 Result 0 infections, 153 central-line days ⁴² Rating SIR: 0.00 ⁴²	0 infections, 153 central-line days ⁴²	0.00 ⁴²
Q1 2010 - Q2 2010 Result N/A infections, N/A central-line days ³³ Rating SIR: N/A ³³	N/A infections, N/A central-line days ³³	N/A ³³
Level III Neonatal ICU Q1 2013 - Q4 2013 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Description Central Line-associated Bloodstream Infection data in the Level III Neonatal ICU summarized as a Standardized Infection Ratio.

SSI Measure	Result	SIR
Total Knee Replacement Surgery Q1 2019 - Q4 2019 Result 1 infections, 96 procedures ¹¹⁴ Rating SIR: N/A ¹¹⁴	1 infections, 96 procedures ¹¹⁴	N/A ¹¹⁴
Description Surgical Site Infections Associated with Total Knee Replacement Surgery Summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2018 - Q4 2018 Result 0 infections, 77 procedures ¹⁵³ Rating SIR: N/A ¹⁵³	0 infections, 77 procedures ¹⁵³	N/A ¹⁵³
Q1 2017 - Q4 2017 Result 0 infections, 103 procedures ¹⁵³ Rating SIR: N/A ¹⁵³	0 infections, 103 procedures ¹⁵³	N/A ¹⁵³
Q1 2016 - Q4 2016 Result 0 infections, 104 procedures ¹⁵³ Rating SIR: N/A ¹⁵³	0 infections, 104 procedures ¹⁵³	N/A ¹⁵³
Q1 2015 - Q4 2015 Result 1 infections, 119 procedures Rating SIR: 0.64	1 infections, 119 procedures	0.64
Q1 2014 - Q4 2014 Result 1 infections, 103 procedures Rating SIR: N/A	1 infections, 103 procedures	N/A
Q3 2013 - Q2 2014 Result 1 infections, 100 procedures ¹¹⁴ Rating SIR: N/A ¹¹⁴	1 infections, 100 procedures ¹¹⁴	N/A ¹¹⁴
Q3 2012 - Q2 2013 Result 1 infections, 104 procedures ¹¹⁴ Rating SIR: N/A ¹¹⁴	1 infections, 104 procedures ¹¹⁴	N/A ¹¹⁴
Q3 2011 - Q2 2012 Result 2 infections, 118 procedures Rating SIR: 1.89	2 infections, 118 procedures	1.89
Q3 2010 - Q2 2011 Result 3 infections, 134 procedures Rating SIR: 2.33	3 infections, 134 procedures	2.33
Coronary Artery Bypass Graft Surgery Q1 2019 - Q4 2019 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸
Description Surgical Site Infections Associated with Coronary Artery Bypass Graft Surgery Summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2018 - Q4 2018 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸
Q1 2016 - Q4 2016 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸
Q1 2015 - Q4 2015 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸
Q1 2014 - Q4 2014 Result N/A infections, N/A procedures Rating SIR: N/A	N/A infections, N/A procedures	N/A
Q3 2013 - Q2 2014 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸
Q3 2012 - Q2 2013 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸
Q3 2011 - Q2 2012 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸
Q3 2010 - Q2 2011 Result N/A infections, N/A procedures ⁴⁸ Rating SIR: N/A ⁴⁸	N/A infections, N/A procedures ⁴⁸	N/A ⁴⁸